Basit öğe kaydını göster

Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.

dc.contributor.authorKESER, GÖKHAN
dc.contributor.authorOnat, Ahmet Mesut
dc.contributor.authorPehlivan, Yavuz
dc.contributor.authorKILIÇ, LEVENT
dc.contributor.authorErtenli, Ihsan
dc.contributor.authorDireskeneli, Haner
dc.contributor.authorOKSEL, FAHRETTİN
dc.contributor.authorDalkilic, Ediz
dc.contributor.authorYilmaz, Sedat
dc.contributor.authorPay, Salih
dc.contributor.authorBalkarli, Ayse
dc.contributor.authorCobankara, Veli
dc.contributor.authorÇETİN, GÖZDE YILDIRIM
dc.contributor.authorÇEFLE, AYŞE
dc.contributor.authorSayarlioglu, Mehmet
dc.contributor.authorYAZICI, AYTEN
dc.contributor.authorAVCI, ALİ
dc.contributor.authorTerzioglu, Ender
dc.contributor.authorÖZBEK, SÜLEYMAN
dc.contributor.authorAKAR, SERVET
dc.contributor.authorGül, Ahmet
dc.contributor.authorErer, B.
dc.contributor.authorHatemi, Gulen
dc.contributor.authorOzguler, Yesim
dc.contributor.authorCan, Meryem
dc.contributor.authorKisacik, Bunyamin
dc.contributor.authorPamuk, Omer
dc.date.accessioned2021-03-03T19:26:30Z
dc.date.available2021-03-03T19:26:30Z
dc.identifier.citationKisacik B., Pamuk O., Onat A. M. , Erer B., Hatemi G., Ozguler Y., Pehlivan Y., KILIÇ L., Ertenli I., Can M., et al., "Tuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.", ARTHRITIS & RHEUMATOLOGY, cilt.66, 2014
dc.identifier.issn2326-5191
dc.identifier.othervv_1032021
dc.identifier.otherav_548b0031-9f88-47f9-99f1-8d05a371b189
dc.identifier.urihttp://hdl.handle.net/20.500.12627/59846
dc.language.isoeng
dc.subjectİmmünoloji ve Romatoloji
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectROMATOLOJİ
dc.titleTuberculosis Reactivation Risk in Patients Treated with Tumor Necrosis Factor Alpha Inhibitors: A Turkish Experience with Higher Mortality and Different Background Diseases.
dc.typeMakale
dc.relation.journalARTHRITIS & RHEUMATOLOGY
dc.contributor.departmentGaziantep Üniversitesi , ,
dc.identifier.volume66
dc.contributor.firstauthorID217563


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster